
Twelve patients of elapid ophitoxaemia presented with neuromuscular paralytic features were given anticholinesterase (Neostigmine) in recommended dosage. In four of these patients, despite neuromuscular paralysis, no ASV was used. All these four patients survived. In eight patients, ASV was used; in three of whom it used in doses less than 50 units, yet patients survived. Of the remaining five, despite use of ASV in higher doses (more than 50 units), two succumbed to death. Eight patients required ventilatory support. Hence, in absence of any definite role of ASV in management of elapid ophitoxaemia (snake bite), use of anticholinesterase drugs alone, with good supportive care and prevention of likely complications, can result in satisfactory outcome.
Adult, Elapid Venoms, Male, Adolescent, Antivenins, India, Snake Bites, Neuromuscular Diseases, Respiration, Artificial, Neostigmine, Survival Rate, Treatment Outcome, Animals, Humans, Paralysis, Female, Cholinesterase Inhibitors, Elapidae, Follow-Up Studies
Adult, Elapid Venoms, Male, Adolescent, Antivenins, India, Snake Bites, Neuromuscular Diseases, Respiration, Artificial, Neostigmine, Survival Rate, Treatment Outcome, Animals, Humans, Paralysis, Female, Cholinesterase Inhibitors, Elapidae, Follow-Up Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
